Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Unicycive Therapeutics (UNCY)

Unicycive Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:UNCY
DateTimeSourceHeadlineSymbolCompany
07/01/202521:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
21/11/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:UNCYUnicycive Therapeutics Inc
15/11/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:UNCYUnicycive Therapeutics Inc
15/11/202400:13Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:UNCYUnicycive Therapeutics Inc
15/11/202400:01Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:UNCYUnicycive Therapeutics Inc
13/11/202422:29Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:UNCYUnicycive Therapeutics Inc
13/11/202413:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
13/11/202412:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:UNCYUnicycive Therapeutics Inc
28/10/202411:03GlobeNewswire Inc.Unicycive Therapeutics Delivers Multiple Poster Presentations Highlighting Development Progress on Oxylanthanum Carbonate (OLC) and UNI-494 at the American Society of Nephrology (ASN) Kidney Week 2024NASDAQ:UNCYUnicycive Therapeutics Inc
16/10/202420:35GlobeNewswire Inc.Unicycive Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on October 17, 2024NASDAQ:UNCYUnicycive Therapeutics Inc
14/10/202411:03GlobeNewswire Inc.Unicycive Therapeutics Announces Late-Breaker Poster Presentation on Oxylanthanum Carbonate (OLC) at the American Society of Nephrology (ASN) Kidney Week 2024NASDAQ:UNCYUnicycive Therapeutics Inc
11/10/202420:02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:UNCYUnicycive Therapeutics Inc
09/10/202411:03GlobeNewswire Inc.Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy VolunteersNASDAQ:UNCYUnicycive Therapeutics Inc
24/09/202411:03GlobeNewswire Inc.Unicycive Therapeutics to Participate in a Fireside Chat at the Virtual Lytham Partners Fall 2024 Investor Conference on October 1, 2024NASDAQ:UNCYUnicycive Therapeutics Inc
16/09/202411:03GlobeNewswire Inc.Unicycive Therapeutics to Present at the Virtual Life Sciences Investor Forum on September 19, 2024NASDAQ:UNCYUnicycive Therapeutics Inc
05/09/202411:03GlobeNewswire Inc.Unicycive Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
03/09/202411:03GlobeNewswire Inc.Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on DialysisNASDAQ:UNCYUnicycive Therapeutics Inc
26/08/202411:03GlobeNewswire Inc.Unicycive Therapeutics to Present Three Posters at the American Society of Nephrology (ASN) Kidney Week 2024NASDAQ:UNCYUnicycive Therapeutics Inc
14/08/202420:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UNCYUnicycive Therapeutics Inc
14/08/202420:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UNCYUnicycive Therapeutics Inc
14/08/202420:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UNCYUnicycive Therapeutics Inc
14/08/202412:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
14/08/202411:10GlobeNewswire Inc.Unicycive Announces Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:UNCYUnicycive Therapeutics Inc
14/08/202411:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:UNCYUnicycive Therapeutics Inc
17/07/202411:03GlobeNewswire Inc.Unicycive Therapeutics Granted Patent on UNI-494 to Treat Acute Kidney Injury by the United States Patent and Trademark Office (USPTO)NASDAQ:UNCYUnicycive Therapeutics Inc
17/07/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:UNCYUnicycive Therapeutics Inc
16/07/202414:31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:UNCYUnicycive Therapeutics Inc
15/07/202420:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
15/07/202420:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
11/07/202411:03GlobeNewswire Inc.Unicycive Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 3rd Annual Kidney Virtual ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:UNCY